CNE100006KG8
CNE100006KG8
CHONGQING GENRIX BIOPHARMACEUTI
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 9.15B EUR | 8.53B EUR | 9.41B EUR | 9.99B EUR |
Enterprise Value | 8.42B EUR | 9.13B EUR | 9.29B EUR | 9.51B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -9.11x | -- | -- | -- |
Price to Sales | 27.03x | 48.36x | 81.35x | 145.68x |
Price to Book | 7.14x | 6.65x | 6.56x | 6.3x |
EV/Revenue | 24.89x | 51.8x | 80.3x | 138.75x |
EV/EBITDA | -15.6x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -6.6% | -6.18% | -3.62% | -2.63% |